Metformin displayed a lowest risk for dementia across diverse antidiabetics, while α-glucosidase inhibitors had the highest risk.
Higher inflammation from early adulthood linked to worse cognition
Jul 08, 2024
Worse executive function and processing speeding were seen with consistently higher or moderate/increasing inflammation.
Vigorous physical activity may preserve cognitive function in high-risk HTN
Jun 24, 2024
High versus low vigorous physical activity was linked to a lower risk of mild cognitive impairment, probable dementia and MCI/probable dementia in a multivariate model.
Individual ability to be mobile in community tied to cognitive function
May 15, 2024
The association may be small and complex, however, the authors say.
Type 2 diabetes tied to accelerated brain aging, cognitive decline
Jun 08, 2022
The authors say the neurological impact may start before diabetes is formally diagnosed.
Link between cognitive ability and body mass index may be biased
Apr 14, 2023
A new study shows that shared family factors may explain previous findings.
Late-life cognitive activity may delay dementia
Jul 14, 2021
Taking up reading, puzzles and games even in one’s 80s may provide cognitive protection.
Psychological interventions may reduce depression in dementia patients
May 04, 2022
Treatments based on cognitive behavioral therapies may reduce depressive symptoms, but evidence is lacking for their effect on anxiety.
Plasma amyloid-beta at midlife linked to later MCI, dementia
Aug 05, 2021
Midlife measurements of plasma amyloid-beta may predict risk for mild cognitive impairment, dementia in late life.